[1] Faghfoori Z, Fazelian S, Shadnoush M, Goodarzi R. Nutritional management in women with polycystic ovary syndrome: A review study. Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S429-S432.
[2] Papakonstantinou E, Kechribari I, Sotirakoglou Κ, Tarantilis P, Gourdomichali T, Michas G, Kravvariti V, Voumvourakis K, Zampelas A. Acute effects of coffee consumption on self-reported gastrointestinal symptoms, blood pressure and stress indices in healthy individuals. Nutr J. 2016 Mar 15;15:26.
[3] Raoofi A, Rezaie MJ, Delbari A, Ghoreishi SA, Sichani PH, Maleki S, Nasiry D, Akhlaghi M, Ebrahimi V, Khaneghah AM. Therapeutic potentials of the caffeine in polycystic ovary syndrome in a rat model: Via modulation of proinflammatory cytokines and antioxidant activity. Allergol Immunopathol (Madr). 2022 Nov 1;50(6):137-146.
[4] Wang, Yue, et al. "Coffee consumption and the risk of polycystic ovary syndrome: evidence from a case-control study." (2021).
[5] Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Caffeinated and alcoholic beverage intake in relation to ovulatory disorder infertility. Epidemiology. 2009 May;20(3):374-81.
[6] Í Soylu L, Jensen A, Juul KE, Kesmodel US, Frederiksen K, Kjaer SK, Hargreave M. Coffee, tea and caffeine consumption and risk of primary infertility in women: a Danish cohort study. Acta Obstet Gynecol Scand. 2018 May;97(5):570-576.
[7] Caffeine[EB/OL]. (2021-09-8)[2023-11-18]. https://medlineplus.gov/caffeine.html